This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Genmab Discloses Managerial Employee...
Regulatory Insider trading

Genmab Discloses Managerial Employee Transactions

Analysis based on 12 articles · First reported Feb 20, 2026 · Last updated Mar 02, 2026

Sentiment
0
Attention
2
Articles
12
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The market impact of these disclosures is neutral, as they represent routine compliance with market abuse regulations. Investors may use this information to track insider activity, but it does not inherently signal a change in Genmab's market sentiment.

Biotechnology Pharmaceuticals
Event Summary

Genmab, an international biotechnology company, has issued several company announcements disclosing transactions made in its shares by managerial employees and their closely associated persons. These disclosures are in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523. Specifically, the announcements detail the vesting and net settlement of restricted stock units granted to Jan van de Winkel and Anthony Pagano on February 24, 2023, as part of their annual bonus achievement. The company has been given power of attorney by these individuals to publish their trading activities. Genmab is headquartered in Copenhagen, Denmark, and has a global presence.

Key Actions
80 Genmab Disclosed managerial employee transactions
60 Jan van de Winkel Had restricted stock units vest and net settle
60 Anthony Pagano Had restricted stock units vest and net settle
Entities Involved
stock
Genmab
Genmab is disclosing transactions made by its managerial employees and closely associated persons in Genmab shares, in accordance with market abuse regulations. This is a routine compliance disclosure and does not indicate any specific positive or negative impact on the company itself.
Importance 100 Sentiment 0
per
Jan van de Winkel
Jan van de Winkel, a managerial employee of Genmab, had restricted stock units granted on February 24, 2023, vest and net settle. This is part of his compensation package.
Importance 50 Sentiment 0
per
Anthony Pagano
Anthony Pagano, a managerial employee of Genmab, had restricted stock units granted on February 24, 2023, vest and net settle. This is part of his compensation package.
Importance 50 Sentiment 0
alliance
European Union
The transactions are disclosed in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, which are regulations from the European Union.
Importance 10 Sentiment 0
govactor
United States===United States Securities and Exchange Commission
Genmab's financial reports and risk factors are filed with the United States===United States Securities and Exchange Commission, indicating compliance with US regulatory requirements.
Importance 10 Sentiment 0
Relationships
Jan van de Winkel related ↔ Genmab
Anthony Pagano related ↔ Genmab
Genmab related ↔ European Union
Genmab related ↔ United States===United States Securities and Exchange Commission
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.